FDA advisory panel backs approval of neoadjuvant pertuzumab for breast cancerSeptember 13, 2013Breast Cancer
Gene study sheds light on response to panitumumab-FOLFOX4 therapySeptember 11, 2013GastroenterologyGastrointestinal Cancer
FDA expands Abraxane approval to include advanced pancreatic cancerSeptember 6, 2013GastroenterologyGastrointestinal Cancer
Perioperative MRI fails to reduce recurrence risk in women with ductal carcinoma in situSeptember 5, 2013Breast Cancer
No increase in cardiovascular risk seen after radiation therapy for DCIS September 4, 2013Breast Cancer